Alx Oncology

ALXONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$282.582 M

$2.10 -0.47%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$101.7M

Loss-making

Shares outstanding

138,276,997

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#242CellectisCLLS$285.0M
#243Eledon PharmaceuticalsELDN$284.8M
#244Alx OncologyALXO$282.6M
#245Veraxa BiotechVRXA$281.4M
#246AdageneADAG$271.5M

Where these numbers come from

Share counts and financials for Alx Oncology are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.